Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Facial Injectable Market, by End-use
1.4.2 North America Facial Injectable Market, by Product
1.4.3 North America Facial Injectable Market, by Application
1.4.4 North America Facial Injectable Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Facial Injectable Market by End-use
3.1 North America MedSpa Market by Country
3.2 North America Dermatology Clinics Market by Country
3.3 North America Hospitals Market by Country
Chapter 4. North America Facial Injectable Market by Product
4.1 North America Botulinum Toxin Type A Market by Country
4.2 North America Calcium Hydroxylapatite (CaHA) Market by Country
4.3 North America Poly-L-Lactic Acid (PLLA) Market by Country
4.4 North America Collagen & PMMA Microspheres Market by Country
4.5 North America Hyaluronic Acid (HA) Market by Country
4.6 North America Others Market by Country
Chapter 5. North America Facial Injectable Market by Application
5.1 North America Facial Line Correction Market by Country
5.2 North America Face Lift Market by Country
5.3 North America Lip Augmentation Market by Country
5.4 North America Acne Scar Treatment Market by Country
5.5 North America Lipoatrophy Treatment Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Facial Injectable Market by Country
6.1 US Facial Injectable Market
6.1.1 US Facial Injectable Market by End-use
6.1.2 US Facial Injectable Market by Product
6.1.3 US Facial Injectable Market by Application
6.2 Canada Facial Injectable Market
6.2.1 Canada Facial Injectable Market by End-use
6.2.2 Canada Facial Injectable Market by Product
6.2.3 Canada Facial Injectable Market by Application
6.3 Mexico Facial Injectable Market
6.3.1 Mexico Facial Injectable Market by End-use
6.3.2 Mexico Facial Injectable Market by Product
6.3.3 Mexico Facial Injectable Market by Application
6.4 Rest of North America Facial Injectable Market
6.4.1 Rest of North America Facial Injectable Market by End-use
6.4.2 Rest of North America Facial Injectable Market by Product
6.4.3 Rest of North America Facial Injectable Market by Application
Chapter 7. Company Profiles
7.1 Ipsen Pharma Biotech SAS
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Merz Pharma GmbH & Co. KGaA
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.3 Suneva Medical, Inc.
7.3.1 Company Overview
7.4 Medytox Inc.
7.4.1 Company Overview
7.5 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Product Launches and Product Expansions:
7.5.2.2 Approvals and Trials:
7.6 Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
7.6.1 Company Overview
7.7 Anika Therapeutics, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Prollenium Medical Technologies Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Acquisition and Mergers:
7.9 Galderma S.A.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.10. Allergan PLC (AbbVie, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
Unique Offerings 